CCDR: Volume 42-9, September 1, 2016: Scientific writing The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.  2016-09-01 2019-01-17 Public Health Agency of Canada open-ouvert@tbs-sct.gc.ca Health and SafetyScientific writingimplementing science articlesqualitative studiesvaccine safetyOntario's Universal Influenza Immunization Programyellow fever vaccineimmunizationseasonal influenza vaccineHepatitis A vaccineEnvironmental AssessmentProtection Against InfluenzaMaternal Immunization CCDR: Volume 42-9, September 1, 2016: Scientific writingHTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-9-september-1-2016.html CCDR: Volume 42-9, September 1, 2016: Scientific writingHTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-9-1er-septembre-2016.html CCDR: Volume 42-9, September 1, 2016: Scientific writingPDF https://www.canada.ca/content/dam/phac-aspc/migration/phac-aspc/publicat/ccdr-rmtc/16vol42/dr-rm42-9/assets/pdf/16vol42_9-eng.pdf CCDR: Volume 42-9, September 1, 2016: Scientific writingPDF https://www.canada.ca/content/dam/phac-aspc/migration/phac-aspc/publicat/ccdr-rmtc/16vol42/dr-rm42-9/assets/pdf/16vol42_9-fra.pdf Implementation science reporting guide - 2016 HTML https://www.canada.ca/content/dam/phac-aspc/migration/phac-aspc/publicat/ccdr-rmtc/16vol42/dr-rm42-9/assets/pdf/16vol42_9-eng.pdf Qualitative studies reporting guide - 2016 HTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-9-1er-septembre-2016/rmtc-volume-42-9-1er-septembre-2016-redaction-scientifique-1.html Overviews reporting guide - 2016 HTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-9-september-1-2016/ccdr-volume-42-9-september-1-2016-scientific-writing-2.html Overviews reporting guide - 2016 HTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-9-1er-septembre-2016/rmtc-volume-42-9-1er-septembre-2016-redaction-scientifique-2.html Influenza vaccine safety in OntarioHTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-9-september-1-2016/ccdr-volume-42-9-september-1-2016-scientific-writing-3.html Influenza vaccine safety in OntarioHTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-9-1er-septembre-2016/rmtc-volume-42-9-1er-septembre-2016-redaction-scientifique-3.html Use of yellow fever vaccine in Canada during a vaccine shortageHTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-9-september-1-2016/ccdr-volume-42-9-september-1-2016-scientific-writing-4.html Use of yellow fever vaccine in Canada during a vaccine shortageHTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-9-1er-septembre-2016/rmtc-volume-42-9-1er-septembre-2016-redaction-scientifique-3.html NACI Statement on Seasonal Influenza Vaccine: 2016–2017HTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-9-september-1-2016/ccdr-volume-42-9-september-1-2016-scientific-writing-5.html NACI Statement on Seasonal Influenza Vaccine: 2016–2017HTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-9-1er-septembre-2016/rmtc-volume-42-9-1er-septembre-2016-redaction-scientifique-5.html NACI Statement on use of Hepatitis A vaccineHTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-9-september-1-2016/ccdr-volume-42-9-september-1-2016-scientific-writing-6.html NACI Statement on use of Hepatitis A vaccineHTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-9-1er-septembre-2016/rmtc-volume-42-9-1er-septembre-2016-redaction-scientifique-6.html Environmental Assessment for Investigational Use of Aedes aegypti OX513AHTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-9-september-1-2016/ccdr-volume-42-9-september-1-2016-scientific-writing-7.html#a2 Environmental Assessment for Investigational Use of Aedes aegypti OX513AHTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-9-1er-septembre-2016/rmtc-volume-42-9-1er-septembre-2016-redaction-scientifique-7.html Duration of Infant Protection Against Influenza Illness Conferred by Maternal Immunization: Secondary Analysis of a Randomized Clinical TrialHTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-9-september-1-2016/ccdr-volume-42-9-september-1-2016-scientific-writing-7.html#a2 Duration of Infant Protection Against Influenza Illness Conferred by Maternal Immunization: Secondary Analysis of a Randomized Clinical TrialHTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-9-1er-septembre-2016/rmtc-volume-42-9-1er-septembre-2016-redaction-scientifique-7.html Implementation science reporting guide - 2016 HTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-9-1er-septembre-2016/rmtc-volume-42-9-1er-septembre-2016-redaction-scientifique.html Qualitative studies reporting guide - 2016 HTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-9-september-1-2016/ccdr-volume-42-9-september-1-2016-scientific-writing-1.html

CCDR: Volume 42-9, September 1, 2016: Scientific writing

The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.

Resources

Resource Name Resource Type Format Language Links
CCDR: Volume 42-9, September 1, 2016: Scientific writing Website HTML English Access
CCDR: Volume 42-9, September 1, 2016: Scientific writing Website HTML French Access
CCDR: Volume 42-9, September 1, 2016: Scientific writing Website PDF English Access
CCDR: Volume 42-9, September 1, 2016: Scientific writing Website PDF French Access
Implementation science reporting guide - 2016  Website HTML English Access
Qualitative studies reporting guide - 2016  Website HTML French Access
Overviews reporting guide - 2016  Website HTML English Access
Overviews reporting guide - 2016  Website HTML French Access
Influenza vaccine safety in Ontario Website HTML English Access
Influenza vaccine safety in Ontario Website HTML French Access
Use of yellow fever vaccine in Canada during a vaccine shortage Website HTML English Access
Use of yellow fever vaccine in Canada during a vaccine shortage Website HTML French Access
NACI Statement on Seasonal Influenza Vaccine: 2016–2017 Website HTML English Access
NACI Statement on Seasonal Influenza Vaccine: 2016–2017 Website HTML French Access
NACI Statement on use of Hepatitis A vaccine Website HTML English Access
NACI Statement on use of Hepatitis A vaccine Website HTML French Access
Environmental Assessment for Investigational Use of Aedes aegypti OX513A Website HTML English Access
Environmental Assessment for Investigational Use of Aedes aegypti OX513A Website HTML French Access
Duration of Infant Protection Against Influenza Illness Conferred by Maternal Immunization: Secondary Analysis of a Randomized Clinical Trial Website HTML English Access
Duration of Infant Protection Against Influenza Illness Conferred by Maternal Immunization: Secondary Analysis of a Randomized Clinical Trial Website HTML French Access
Implementation science reporting guide - 2016  Website HTML French Access
Qualitative studies reporting guide - 2016  Website HTML English Access